Human host cell for producing recombinant proteins with high quality and quantity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 29, 2013
Grant Date -
Mar 17, 2011
app pub date -
Apr 10, 2009
filing date -
Apr 12, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a human host cell generated from fusion of a human embryonic kidney-derived cell and a human B-cell-derived cell, by using genetic engineering techniques. The human host cell with stable characteristics well preserved may be efficiently used to produce heterologous desired recombinant protein-based pharmaceuticals.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully